May 4, 2005 by Brian GormanRelaxing on the RiverCharles River's full suite of services looks like a winning concept.
May 3, 2005 by Brian GormanMarriage of ConvenienceLockheed Martin and Boeing to join forces on U.S. government rocket contracts.
May 2, 2005 by Brian GormanCardinal Health Perks UpThe drug company is working through its problems, which should make for a brighter fiscal 2006.
Apr 29, 2005 by Brian GormanKellogg's Hearty ResultsKellogg is performing well, but the stock is already fairly pricey.
Apr 28, 2005 by Brian GormanPPD Branches OutPPD is right in diversifying, but its strategy carries its own risk.
Apr 27, 2005 by Brian GormanCautious on MedcoMedco's earnings were respectable, but for now investors may want to step back.
Apr 26, 2005 by Brian GormanBoeing CelebratesThe latest order from Air Canada provides further confirmation that the 787 is a winner.
Apr 25, 2005 by Brian GormanLeaning on a Stronger CovanceThe drug development services company is helping big pharmaceutical firms.
Apr 22, 2005 by Brian GormanBaxter Is on the MendThe medical products company continues to right itself for a brighter future.
Apr 20, 2005 by Brian GormanPricier News for AP UsersThe Associated Press' decision to charge licensing fees for online content will make the battle for ad dollars more difficult.
Apr 19, 2005 by Brian GormanCeladon Trucks OnThe little trucking services firm is gaining momentum from skillful management and external trends.
Apr 18, 2005 by Brian GormanTarget Offers Food for ThoughtThe company's latest foray into premium products may be a mistake.
Apr 15, 2005 by Brian GormanRelief Pitch for Eli LillyA ruling upholding the Zyprexa patent is good news for Lilly, but promising drugs in the pipeline are even more encouraging.
Apr 14, 2005 by Brian GormanNovartis Moves on Multiple FrontsEven with its investment in a potential blockbuster, Novartis remains remarkably diversified.
Apr 13, 2005 by Brian GormanToyota's Domestic FrontThe Japanese giant's investments in the U.S. will continue to erode loyalty to U.S. brands.
Apr 12, 2005 by Brian GormanGenentech's Cancer QuestThe company's achievements in lung cancer further strengthen its reputation as a cancer fighter.
Apr 7, 2005 by Brian GormanMerck Soldiers OnThe drug company's experimental HPV treatment has significant potential.
Apr 6, 2005 by Brian GormanStarbucks' Coffeehouse RockStarbucks is taking another step in marketing its way into the fabric of American culture.
Apr 5, 2005 by Brian GormanAbbott's Pregnant OpportunityThe drug company taps into a significant market with its new products for expecting moms.
